JP2006508178A5 - - Google Patents

Download PDF

Info

Publication number
JP2006508178A5
JP2006508178A5 JP2004571158A JP2004571158A JP2006508178A5 JP 2006508178 A5 JP2006508178 A5 JP 2006508178A5 JP 2004571158 A JP2004571158 A JP 2004571158A JP 2004571158 A JP2004571158 A JP 2004571158A JP 2006508178 A5 JP2006508178 A5 JP 2006508178A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
alkyl
group
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004571158A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006508178A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/028392 external-priority patent/WO2004094370A2/en
Publication of JP2006508178A publication Critical patent/JP2006508178A/ja
Publication of JP2006508178A5 publication Critical patent/JP2006508178A5/ja
Withdrawn legal-status Critical Current

Links

JP2004571158A 2002-09-10 2003-09-10 抗菌性ピラゾールカルボン酸ヒドラジド Withdrawn JP2006508178A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40943902P 2002-09-10 2002-09-10
PCT/US2003/028392 WO2004094370A2 (en) 2002-09-10 2003-09-10 Antibacterial pyrazole carboxylic acid hydrazides

Publications (2)

Publication Number Publication Date
JP2006508178A JP2006508178A (ja) 2006-03-09
JP2006508178A5 true JP2006508178A5 (cg-RX-API-DMAC10.html) 2007-09-13

Family

ID=33309471

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004571158A Withdrawn JP2006508178A (ja) 2002-09-10 2003-09-10 抗菌性ピラゾールカルボン酸ヒドラジド

Country Status (6)

Country Link
US (1) US20060258729A1 (cg-RX-API-DMAC10.html)
EP (1) EP1549143A2 (cg-RX-API-DMAC10.html)
JP (1) JP2006508178A (cg-RX-API-DMAC10.html)
AU (1) AU2003303953B2 (cg-RX-API-DMAC10.html)
CA (1) CA2497410A1 (cg-RX-API-DMAC10.html)
WO (1) WO2004094370A2 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006017505A2 (en) * 2004-08-04 2006-02-16 Schering Corporation Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
US7786139B2 (en) 2006-11-21 2010-08-31 Omeros Corporation PDE10 inhibitors and related compositions and methods
WO2011031935A1 (en) * 2009-09-11 2011-03-17 Glsynthesis Inc. Selective antibacterials for clostridium difficile infections
WO2014059429A2 (en) * 2012-10-12 2014-04-17 Health Research, Inc. Small molecules inhibiting oncoprotein myc
US20240139191A1 (en) * 2020-12-14 2024-05-02 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Small molecules as larp1 ligands
UY39882A (es) * 2021-08-02 2023-06-15 Eurofarma Laboratorios S A COMPUESTOS NACILHIDRAZÓNICOS INHIBIDORES DE Nav 1.7 Y/O Nav 1.8, SUS PROCESOS DE OBTENCIÓN, COMPOSICIONES, USOS, MÉTODOS DE TRATAMIENTO DE ESTOS Y KITS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232685B2 (en) * 2001-12-19 2007-06-19 The Regents Of The Universtiy Of California Cell lines with latent immunodeficiency virus and methods of use thereof
WO2003105840A2 (en) * 2002-06-17 2003-12-24 The Pennsylvania State Research Foundation Sphingosine kinase inhibitors

Similar Documents

Publication Publication Date Title
EP1432705B1 (en) Dual action antibiotics
JP2004502752A5 (cg-RX-API-DMAC10.html)
RU2410386C2 (ru) Новые соединения, обладающие антибактериальной активностью
WO2004062601A3 (en) Antibacterial agents
DE60039238D1 (de) C-2-modifizierte erythromycinderivate
WO2004096823A3 (en) Novel ketolide derivatives
AP2003002942A0 (en) New derivatives of oxazolidinones as bacterial agents
WO2004087728A3 (en) 6,11-3c-bicyclic 9a-azalide derivatives
US20040132764A1 (en) Antibiotics for the treatment of infections in acidic environments
IL87144A (en) Pharmaceutical preparations containing naphthyridine carboxylic acids and process
JP2001072684A5 (cg-RX-API-DMAC10.html)
US7812008B2 (en) 9-substituted tetracyclines
WO2003066064A2 (en) Methods of resistant bacterial disease treatment using metal-complexed tetracycline antibiotics
EP1101769A3 (en) Nitrogen containing erythromycin derivatives
WO2006063039A3 (en) 3, 6-bicyclolides
JP2000026494A5 (cg-RX-API-DMAC10.html)
JP2005504734A5 (cg-RX-API-DMAC10.html)
CA2451768A1 (en) Peptoid compounds
HRP20120634T1 (hr) Antibiotik 107891, njegovi faktori, farmaceutski prihvatljive soli i sastavi, te njihova uporaba
Sakurai et al. Synthesis and structure-activity relationships of 7-(2-aminoalkyl) morpholinoquinolones as anti-Helicobacter pylori agents
Foroumadi et al. Synthesis and in‐vitro antibacterial activity of new N‐substituted piperazinyl quinolones
NO20015346D0 (no) Haloderivater av 9-deoksy-9A-aza-9A-homoerytromycin A
JP2002507616A5 (cg-RX-API-DMAC10.html)
US20040044006A1 (en) Methods of use of quinolone compounds against pneumococcal and haemophilus bacteria
IL183153A0 (en) 8a, 9-DIHYDRO-4a-H-ISOTHIAZOLO[5,4-b]QUINOLINE-3,4-DIONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS